Molecular Mechanisms of L-DOPA-Induced Dyskinesia

Forskningsoutput: Kapitel i bok/rapport/Conference proceedingKapitel samlingsverkForskningPeer review

Sammanfattning

The dopamine (DA) precursor, 3,4-dihydroxyphenyl-L-alanine (L-DOPA), is the most effective treatment for Parkinson's disease (PD), but causes dyskinesias (abnormal involuntary movements) in the vast majority of patients. There is a wide consensus that L-DOPA-induced dyskinesia (LID) depends on both pre- and postsynaptic disturbances of the nigrostriatal DA transmission. Presynaptically, LID is associated with abnormal DA release and defective DA clearance, which converge to cause large swings in brain DA levels concomitant with the medication. Postsynaptically, LID is associated with a dysregulation of intracellular signaling and gene expression downstream of the D1 DA receptor. These phenomena are particularly well studied in the striatum and are thus the main topic of this chapter. In addition, the chapter reviews studies that have revealed associations between LID and different types of abnormalities in glutamatergic and GABAergic transmission within cortico-basal ganglia circuits.

Originalspråkengelska
Titel på värdpublikationHandbook of Behavioral Neuroscience
FörlagElsevier
Sidor857-871
Antal sidor15
Volym24
DOI
StatusPublished - 2017

Publikationsserier

NamnHandbook of Behavioral Neuroscience
Volym24
ISSN (tryckt)15697339

Ämnesklassifikation (UKÄ)

  • Neurovetenskaper

Fingeravtryck

Utforska forskningsämnen för ”Molecular Mechanisms of L-DOPA-Induced Dyskinesia”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här